{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:23Z","timestamp":1760244923926},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1053\/sonc.2003.50049","type":"journal-article","created":{"date-parts":[[2003,4,28]],"date-time":"2003-04-28T19:53:00Z","timestamp":1051559580000},"page":"161-164","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation"],"prefix":"10.1053","volume":"30","author":[{"given":"Derek","family":"Leitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Barrans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger G.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/sonc.2003.50049_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1309\/4LCN-JMPG-5U71-UWQB","article-title":"Waldenstr\u00f6m macroglobulinemia: Development of diagnostic criteria and identification of prognostic factors","volume":"116","author":"Owen","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/sonc.2003.50049_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1200\/JCO.2000.18.1.214","article-title":"Waldenstr\u00f6m's macroglobulinemia: Clinical featurs, complications, and management","volume":"18","author":"Dimopoulos","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/sonc.2003.50049_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1099-1069(200006)18:2<41::AID-HON654>3.0.CO;2-W","article-title":"Waldenstr\u00f6m's macroglobulinaemia: Laboratory diagnosis and treatment","volume":"18","author":"Owen","year":"2000","journal-title":"Haematol Oncol"},{"key":"10.1053\/sonc.2003.50049_bib4","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant Rel\/NF\u03baB genes and activity in human cancer","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/sonc.2003.50049_bib5","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1038\/sj.onc.1203238","article-title":"Control of apoptosis by Rel\/NF\u03baB transcription factors","volume":"18","author":"Barkett","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/sonc.2003.50049_bib6","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","article-title":"The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the (11;18)(q21;q21) associated with MALT lymphomas","volume":"93","author":"Dierlamm","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sonc.2003.50049_bib7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1097-2765(00)00094-0","article-title":"Identification of paracaspases and metacaspases: Two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma","volume":"6","author":"Uren","year":"2000","journal-title":"Mol Cell"},{"key":"10.1053\/sonc.2003.50049_bib8","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","article-title":"Bcl10 and MALT1, Independent targets of chromosomal translocation in MALT lymphoma, co-operate in a novel NF\u03baB signaling pathway","volume":"276","author":"Lucas","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1053\/sonc.2003.50049_bib9","first-page":"244","article-title":"The molecular biology of MALT lymphoma","author":"Gasgoyne","year":"2001"},{"key":"10.1053\/sonc.2003.50049_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1182\/blood.V99.4.1398","article-title":"Bcl-10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear Bcl-10 expression","volume":"99","author":"Maes","year":"2002","journal-title":"Blood"},{"key":"10.1053\/sonc.2003.50049_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-4608(99)00156-9","article-title":"Primary macroglobulinemia with t(11,18) (q21,q21)","volume":"117","author":"Hirase","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/sonc.2003.50049_bib12","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/sonc.2003.50049_bib13","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V99.11.4079","article-title":"Biologic sequelae of nuclear factor-\u03baB blockade in multiple myeloma: Therapeutic applications","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Blood"},{"key":"10.1053\/sonc.2003.50049_bib14","first-page":"4996","article-title":"Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model","volume":"62","author":"LeBlanc","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/sonc.2003.50049_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1309\/44HW-5YCJ-FLLP-3R56","article-title":"The proteasome: A new target for novel drug therapies","volume":"116","author":"Elliott","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"suppl 1","key":"10.1053\/sonc.2003.50049_bib16","first-page":"347a","article-title":"Waldenstr\u00f6m's macroglobulinemia is characterised by a memory B-cell immunophenotype and the absence of immunoglobulin translocations","volume":"100","author":"Leitch","year":"2002","journal-title":"Blood"},{"key":"10.1053\/sonc.2003.50049_bib17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.onc.1203412","article-title":"Selective activation of NF\u03baB subunits in human breast cancer: Potential roles for NF\u03baB2\/p52 and for bcl-3","volume":"19","author":"Cogswell","year":"2000","journal-title":"Oncogene"},{"key":"10.1053\/sonc.2003.50049_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1097-2765(00)80066-0","article-title":"Phosphorylation of NF\u03baB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the co-activator CBP\/p300","volume":"1","author":"Zhong","year":"1998","journal-title":"Mol Cell"},{"key":"10.1053\/sonc.2003.50049_bib19","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood.V100.8.2996","article-title":"Waldenstr\u00f6m's macroglobulinemia neoplastic cells lack IgH translocations but have frequent 6q deletions","volume":"100","author":"Schop","year":"2002","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403700694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403700694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T16:06:01Z","timestamp":1584633961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775403700694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0093775403700694"],"URL":"https:\/\/doi.org\/10.1053\/sonc.2003.50049","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}